Long-Acting Injectable Risperidone Compared with Zuclopenthixol in the Treatment of Schizophrenia with Substance Abuse Comorbidity

Gabriel Rubio(Madrid Health Service), Cecilio Álamo(Universidad de Alcalá), Francisco López‐Muñoz(Universidad de Alcalá), Miguel Ángel Jiménez‐Arriero(Research Institute Hospital 12 de Octubre), G. Ponce(Research Institute Hospital 12 de Octubre)
The Canadian Journal of Psychiatry
July 1, 2006
Cited by 107


Related Papers